Wolverine Trading’s ARS Pharmaceuticals SPRY Stock Holding History

Wolverine Trading’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$219K	Sell	22,500 -26,200	-54%	-$376K	﹤0.01%	4818
2025 Q2	$886K	Buy	+48,700	New	+$703K	﹤0.01%	2431
2025 Q1	–	Sell	-37,700	Closed	-$400K	–	5753
2024 Q4	$400K	Sell	37,700 -17,600	-32%	-$246K	﹤0.01%	3667
2024 Q3	$792K	Sell	55,300 -81,700	-60%	-$972K	﹤0.01%	2594
2024 Q2	$1.17M	Buy	137,000 +117,500	+603%	+$1.04M	﹤0.01%	2051
2024 Q1	$199K	Buy	+19,500	New	+$145K	﹤0.01%	3813
2023 Q4	–	Sell	-20,000	Closed	-$75.6K	–	5172
2023 Q3	$75.6K	Buy	+20,000	New	+$131K	﹤0.01%	4082

Other funds holding SPRY

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wolverine Trading's SPRY Position: Q3 2025 in Review

Wolverine Trading opened a new position in ARS Pharmaceuticals (SPRY) in Q3 2025: 24,266 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #4715 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in SPRY as recently as Q4 2024.

Wolverine Trading first reported a position in SPRY in Q2 2024 and has held it in 4 quarters since. The position peaked at $283K in Q3 2024. 188 funds tracked by Wall St. Rank hold SPRY as of Q3 2025.

Wolverine Trading held 24,266 shares of ARS Pharmaceuticals worth $236K as of Q3 2025.
ARS Pharmaceuticals was a new Wolverine Trading position in Q3 2025.
ARS Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4715 holding.
Wolverine Trading first reported a position in ARS Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
Wolverine Trading's ARS Pharmaceuticals position peaked at $283K in Q3 2024.
188 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.